Literature DB >> 31598041

Validation of the Risk Score for Maternal Cardiac Complications in Women with Cardiac Disease in Pregnancy: A Retrospective Study.

C N Sheela1, Nekkilady Veni2, Ponnusamy Vinotha3, Selvam Sumithra4.   

Abstract

AIM OF THE STUDY: To validate the new cardiac risk scoring system, Sheela's Cardiac Disease in Pregnancy (SHE-CDIP), in predicting the cardiac complications in women with cardiac disease in pregnancy.
MATERIALS AND METHODS: The study was conducted at a tertiary care hospital in South India, over a period of 5 years from January 2010 to January 2015. Pregnant women with heart disease included in this study were 102, and data was collected from medical records. Risk Score was calculated at booking according to both the new scoring system (SHE-CDIP) and the standard CARPREG scoring system. The validation was done by assessing the ability of the new scoring system to predict maternal cardiac complications by comparing with the CARPREG scoring system. STATISTICAL METHODS: The validation of the SHE-CDIP score was done against CARPREG score using cross tabulation between current cardiac risk score with CARPREG score. McNemar square test was done to compare the proportion between two scoring methods. Agreement between CARPREG and SHE-CDIP risk score was analyzed using Kappa statistics, and accuracy was reported.
RESULTS: Comparing the two risk scores using Kappa statistics, accuracy and good agreement were noted (kappa = 0.70). Sensitivity of 83%, specificity of 88%, positive predictive value of 86% and negative predictive value of 84% for the SHE-CDIP scoring system were noted.
CONCLUSION: The new risk score (SHE-CDIP) would be useful to stratify the risk in Indian cohort of women with cardiac disease in pregnancy as it is population specific. © Federation of Obstetric & Gynecological Societies of India 2019.

Entities:  

Keywords:  CARPREG score; Cardiac diseases; Pregnancy; Pulmonary hypertension; Risk score

Year:  2019        PMID: 31598041      PMCID: PMC6765037          DOI: 10.1007/s13224-019-01226-2

Source DB:  PubMed          Journal:  J Obstet Gynaecol India        ISSN: 0975-6434


  17 in total

1.  [Pregnancy outcomes of 103 women with pulmonary arterial hypertension].

Authors:  Bin Li; Xiao-Yuan Sun; Ke-Fang Wang
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2013-09

2.  Prediction of complications in pregnant women with cardiac diseases referred to a tertiary center.

Authors:  Nicole Jastrow; Philippe Meyer; Paul Khairy; Lise-Andrée Mercier; Annie Dore; François Marcotte; Line Leduc
Journal:  Int J Cardiol       Date:  2010-07-24       Impact factor: 4.164

3.  Incidence and predictors of obstetric and fetal complications in women with structural heart disease.

Authors:  Iris M van Hagen; Jolien W Roos-Hesselink; Valentina Donvito; Csilla Liptai; Marielle Morissens; Daniel J Murphy; Laura Galian; Nooshin Mohd Bazargani; Jérôme Cornette; Roger Hall; Mark R Johnson
Journal:  Heart       Date:  2017-04-04       Impact factor: 5.994

4.  [Analysis of high risk factors for patient death and its clinical characteristics on pregnancy associated with pulmonary arterial hypertension].

Authors:  Zhaoliang Bao; Jun Zhang; Dong Yang; Xiaohui Xu
Journal:  Zhonghua Fu Chan Ke Za Zhi       Date:  2014-07

5.  Diagnostic accuracy of clinical criteria for identifying systolic and diastolic heart failure: cross-sectional study.

Authors:  Ana Maestre; Vicente Gil; Javier Gallego; José Aznar; Antonia Mora; Alberto Martín-Hidalgo
Journal:  J Eval Clin Pract       Date:  2009-02       Impact factor: 2.431

6.  Prospective validation and assessment of cardiovascular and offspring risk models for pregnant women with congenital heart disease.

Authors:  Ali Balci; Krystyna M Sollie-Szarynska; Antoinette G L van der Bijl; Titia P E Ruys; Barbara J M Mulder; Jolien W Roos-Hesselink; Arie P J van Dijk; Elly M C J Wajon; Hubert W Vliegen; Willem Drenthen; Hans L Hillege; Jan G Aarnoudse; Dirk J van Veldhuisen; Petronella G Pieper
Journal:  Heart       Date:  2014-07-17       Impact factor: 5.994

Review 7.  The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.

Authors:  Syed S Mahmood; Daniel Levy; Ramachandran S Vasan; Thomas J Wang
Journal:  Lancet       Date:  2013-09-29       Impact factor: 79.321

8.  Global cardiac risk assessment in the Registry Of Pregnancy And Cardiac disease: results of a registry from the European Society of Cardiology.

Authors:  Iris M van Hagen; Eric Boersma; Mark R Johnson; Sara A Thorne; William A Parsonage; Pilar Escribano Subías; Agata Leśniak-Sobelga; Olga Irtyuga; Khaled A Sorour; Nasser Taha; Aldo P Maggioni; Roger Hall; Jolien W Roos-Hesselink
Journal:  Eur J Heart Fail       Date:  2016-03-22       Impact factor: 15.534

9.  Cardiac complications during pregnancy are better predicted with the modified WHO risk score.

Authors:  A Pijuan-Domènech; L Galian; M Goya; M Casellas; C Merced; I Ferreira-Gonzalez; J R Marsal-Mora; L Dos-Subirà; M T Subirana-Domènech; V Pedrosa; F Baró-Marine; S Manrique; J Casaldàliga-Ferrer; P Tornos; L Cabero; D Garcia-Dorado
Journal:  Int J Cardiol       Date:  2015-05-15       Impact factor: 4.164

Review 10.  Pregnancy complicated by valvular heart disease: an update.

Authors:  Michael Nanna; Kathleen Stergiopoulos
Journal:  J Am Heart Assoc       Date:  2014-06-05       Impact factor: 5.501

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.